메뉴 건너뛰기




Volumn 36, Issue 10, 2012, Pages 1472-1476

Utility of GATA3 immunohistochemistry in differentiating urothelial carcinoma from prostate adenocarcinoma and squamous cell carcinomas of the uterine cervix, anus, and lung

Author keywords

cervical carcinoma; GATA3; prostate adenocarcinoma; squamous cell carcinoma; urothelial carcinoma

Indexed keywords

GATA3 PROTEIN, HUMAN; TRANSCRIPTION FACTOR GATA 3;

EID: 84866607353     PISSN: 01475185     EISSN: 15320979     Source Type: Journal    
DOI: 10.1097/PAS.0b013e318260cde7     Document Type: Article
Times cited : (139)

References (19)
  • 1
    • 33847126689 scopus 로고    scopus 로고
    • Gata-3 is an essential regulator of mammary-gland morphogenesis and luminal-cell differentiation
    • Asselin-Labat ML, Sutherland KD, Barker H, et al. Gata-3 is an essential regulator of mammary-gland morphogenesis and luminal-cell differentiation. Nat Cell Biol. 2007;9:201-209.
    • (2007) Nat Cell Biol , vol.9 , pp. 201-209
    • Asselin-Labat, M.L.1    Sutherland, K.D.2    Barker, H.3
  • 2
    • 73949087506 scopus 로고    scopus 로고
    • GATA3 in development and cancer differentiation: Cells GATA have it!
    • Chou J, Provot S, Werb Z. GATA3 in development and cancer differentiation: cells GATA have it! J Cell Physiol. 2010;222:42-49.
    • (2010) J Cell Physiol , vol.222 , pp. 42-49
    • Chou, J.1    Provot, S.2    Werb, Z.3
  • 3
    • 41549107036 scopus 로고    scopus 로고
    • GATA-3 and the regulation of the mammary luminal cell fate
    • Kouros-Mehr H, Kim JW, Bechis SK, et al. GATA-3 and the regulation of the mammary luminal cell fate. Curr Opin Cell Biol. 2008;20:164-170.
    • (2008) Curr Opin Cell Biol , vol.20 , pp. 164-170
    • Kouros-Mehr, H.1    Kim, J.W.2    Bechis, S.K.3
  • 4
    • 79960036820 scopus 로고    scopus 로고
    • GATA transcription factors and cancer
    • Zheng R, Blobel GA. GATA transcription factors and cancer. Genes Cancer. 2010;1:1178-1188.
    • (2010) Genes Cancer. , vol.1 , pp. 1178-1188
    • Zheng, R.1    Blobel, G.A.2
  • 5
    • 62849083671 scopus 로고    scopus 로고
    • Expression of the urothelial differentiation markers GATA3 and placental S100 (S100P) in female genital tract transitional cell proliferations
    • Esheba GE, Longacre TA, Atkins KA, et al. Expression of the urothelial differentiation markers GATA3 and placental S100 (S100P) in female genital tract transitional cell proliferations. Am J Surg Pathol. 2009;33:347-353.
    • (2009) Am J Surg Pathol , vol.33 , pp. 347-353
    • Esheba, G.E.1    Longacre, T.A.2    Atkins, K.A.3
  • 6
    • 34247630071 scopus 로고    scopus 로고
    • Placental S100 (S100P) and GATA3: Markers for transitional epithelium and urothelial carcinoma discovered by complementary DNA microarray
    • Higgins JP, Kaygusuz G, Wang L, et al. Placental S100 (S100P) and GATA3: markers for transitional epithelium and urothelial carcinoma discovered by complementary DNA microarray. Am J Surg Pathol. 2007;31:673-680.
    • (2007) Am J Surg Pathol , vol.31 , pp. 673-680
    • Higgins, J.P.1    Kaygusuz, G.2    Wang, L.3
  • 7
    • 33749018789 scopus 로고    scopus 로고
    • Pleomorphic giant cell adenocarcinoma of the prostate: Report of 6 cases
    • Parwani AV, Herawi M, Epstein JI. Pleomorphic giant cell adenocarcinoma of the prostate: report of 6 cases. Am J Surg Pathol. 2006;30:1254-1259.
    • (2006) Am J Surg Pathol , vol.30 , pp. 1254-1259
    • Parwani, A.V.1    Herawi, M.2    Epstein, J.I.3
  • 8
    • 34547643155 scopus 로고    scopus 로고
    • Immunohistochemical differentiation of high-grade prostate carcinoma from urothelial carcinoma
    • Chuang AY, DeMarzo AM, Veltri RW, et al. Immunohistochemical differentiation of high-grade prostate carcinoma from urothelial carcinoma. Am J Surg Pathol. 2007;31:1246-1255.
    • (2007) Am J Surg Pathol , vol.31 , pp. 1246-1255
    • Chuang, A.Y.1    Demarzo, A.M.2    Veltri, R.W.3
  • 9
    • 0031723377 scopus 로고    scopus 로고
    • Thrombomodulin expression in transitional cell carcinoma
    • Ordonez NG. Thrombomodulin expression in transitional cell carcinoma. Am J Clin Pathol. 1998;110:385-390.
    • (1998) Am J Clin Pathol , vol.110 , pp. 385-390
    • Ordonez, N.G.1
  • 10
    • 0037215340 scopus 로고    scopus 로고
    • Potential utility of uroplakin III, thrombomodulin, high molecular weight cytokeratin, and cytoker-atin 20 in noninvasive, invasive, and metastatic urothelial (transitional cell) carcinomas
    • Parker DC, Folpe AL, Bell J, et al. Potential utility of uroplakin III, thrombomodulin, high molecular weight cytokeratin, and cytoker-atin 20 in noninvasive, invasive, and metastatic urothelial (transitional cell) carcinomas. Am J Surg Pathol. 2003;27:1-10.
    • (2003) Am J Surg Pathol , vol.27 , pp. 1-10
    • Parker, D.C.1    Folpe, A.L.2    Bell, J.3
  • 11
    • 0037324298 scopus 로고    scopus 로고
    • High molecular weight cytokeratin antibody (clone 34betaE12): A sensitive marker for differentiation of high-grade invasive urothelial carcinoma from prostate cancer
    • Varma M, Morgan M, Amin MB, et al. High molecular weight cytokeratin antibody (clone 34betaE12): a sensitive marker for differentiation of high-grade invasive urothelial carcinoma from prostate cancer. Histopathology. 2003;42:167-172.
    • (2003) Histopathology , vol.42 , pp. 167-172
    • Varma, M.1    Morgan, M.2    Amin, M.B.3
  • 12
    • 0035184548 scopus 로고    scopus 로고
    • Value of p63 and cytokeratin 5/6 as immunohistochemical markers for the differential diagnosis of poorly differentiated and undifferentiated carcinomas
    • Kaufmann O, Fietze E, Mengs J, et al. Value of p63 and cytokeratin 5/6 as immunohistochemical markers for the differential diagnosis of poorly differentiated and undifferentiated carcinomas. Am J Clin Pathol. 2001;116:823-830.
    • (2001) Am J Clin Pathol , vol.116 , pp. 823-830
    • Kaufmann, O.1    Fietze, E.2    Mengs, J.3
  • 13
    • 33846606406 scopus 로고    scopus 로고
    • Immunohistochemical staining for p63 is useful in the diagnosis of anal squamous cell carcinomas
    • Owens SR, Greenson JK. Immunohistochemical staining for p63 is useful in the diagnosis of anal squamous cell carcinomas. Am J Surg Pathol. 2007;31:285-290.
    • (2007) Am J Surg Pathol , vol.31 , pp. 285-290
    • Owens, S.R.1    Greenson, J.K.2
  • 14
    • 0034986554 scopus 로고    scopus 로고
    • Histologic and immunophe-notypic classification of cervical carcinomas by expression of the p53 homologue p63: A study of 250 cases
    • Wang TY, Chen BF, Yang YC, et al. Histologic and immunophe-notypic classification of cervical carcinomas by expression of the p53 homologue p63: a study of 250 cases. Hum Pathol. 2001;32:479-486.
    • (2001) Hum Pathol. , vol.32 , pp. 479-486
    • Wang, T.Y.1    Chen, B.F.2    Yang, Y.C.3
  • 15
    • 0036724297 scopus 로고    scopus 로고
    • Can basal cells be seen in adenocarcinoma of the prostate?: An immunohistochemical study using high molecular weight cytokeratin (clone 34betaE12) antibody
    • Oliai BR, Kahane H, Epstein JI. Can basal cells be seen in adenocarcinoma of the prostate?: an immunohistochemical study using high molecular weight cytokeratin (clone 34betaE12) antibody. Am J Surg Pathol. 2002;26:1151-1160.
    • (2002) Am J Surg Pathol , vol.26 , pp. 1151-1160
    • Oliai, B.R.1    Kahane, H.2    Epstein, J.I.3
  • 16
    • 0034424842 scopus 로고    scopus 로고
    • Uroplakin III is a highly specific and moderately sensitive immunohistochemical marker for primary and metastatic urothelial carcinomas
    • Kaufmann O, Volmerig J, Dietel M. Uroplakin III is a highly specific and moderately sensitive immunohistochemical marker for primary and metastatic urothelial carcinomas. Am J Clin Pathol. 2000;113:683-687.
    • (2000) Am J Clin Pathol. , vol.113 , pp. 683-687
    • Kaufmann, O.1    Volmerig, J.2    Dietel, M.3
  • 17
    • 0345189361 scopus 로고    scopus 로고
    • Impaired p63 expression associates with poor prognosis and uroplakin III expression in invasive urothelial carcinoma of the bladder
    • Koga F, Kawakami S, Fujii Y, et al. Impaired p63 expression associates with poor prognosis and uroplakin III expression in invasive urothelial carcinoma of the bladder. Clin Cancer Res. 2003;9:5501-5507.
    • (2003) Clin Cancer Res , vol.9 , pp. 5501-5507
    • Koga, F.1    Kawakami, S.2    Fujii, Y.3
  • 18
    • 79954531419 scopus 로고    scopus 로고
    • Different immunohis-tochemical and ultrastructural phenotypes of squamous differentiation in bladder cancer
    • Gaisa NT, Braunschweig T, Reimer N, et al. Different immunohis-tochemical and ultrastructural phenotypes of squamous differentiation in bladder cancer. Virchows Arch. 2011;458:301-312.
    • (2011) Virchows Arch , vol.458 , pp. 301-312
    • Gaisa, N.T.1    Braunschweig, T.2    Reimer, N.3
  • 19
    • 48349083444 scopus 로고    scopus 로고
    • Loss expression of uroplakin III is associated with clinicopathologic features of aggressive bladder cancer
    • Matsumoto K, Satoh T, Irie A, et al. Loss expression of uroplakin III is associated with clinicopathologic features of aggressive bladder cancer. Urology. 2008;72:444-449.
    • (2008) Urology , vol.72 , pp. 444-449
    • Matsumoto, K.1    Satoh, T.2    Irie, A.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.